Neogenomics Inc (NEO)

Oct 01, 2026

NeoGenomics, Inc. (NEO) Stock Forecasts - Yahoo Finance

Oct 01, 2026

Sep 30, 2026

Zacks Research Downgrades NeoGenomics (NASDAQ:NEO) to Hold - MarketBeat

Sep 30, 2026

Sep 29, 2026

NeoGenomics stock trades at EUR 17.04 after Q2 EPS beat - AD HOC NEWS

Sep 29, 2026

Sep 25, 2026

NeoGenomics, Inc. (NEO) stock price, news, quote and history - au.finance.yahoo.com

Sep 25, 2026

Sep 24, 2026

Is NeoGenomics Inc (NEO) Overvalued After 6.5% Rally? GF Value S - GuruFocus

Sep 24, 2026

Sep 24, 2026

NeoGenomics (NASDAQ:NEO) Trading 4.8% HigherHere's Why - MarketBeat

Sep 24, 2026

Sep 24, 2026

NeoGenomics, Inc. (NEO) Stock forecasts - Yahoo Finance Singapore

Sep 24, 2026

Sep 23, 2026

NeoGenomics stock falls 2.81 percent after Q2 revenue beat - AD HOC NEWS

Sep 23, 2026

Sep 22, 2026

Precision Oncology Expansion Could Be A Game Changer For NeoGenomics Stock - Simply Wall Street

Sep 22, 2026

Sep 22, 2026

Liquidity Mapping Around (NEO) Price Events - Stock Traders Daily

Sep 22, 2026

Sep 22, 2026

NeoGenomics, Inc. (NEO) Stock Analysis: Strong Buy Ratings Amid 11.2% Revenue Growth - DirectorsTalk Interviews

Sep 22, 2026

Sep 22, 2026

NeoGenomics (NEO) Expands Precision Oncology Focus, Is The Stock Fairly Valued? - Yahoo Finance

Sep 22, 2026

Sep 21, 2026

Is NeoGenomics’ (NEO) Community NGS Push Quietly Redefining Its Core Earnings Engine? - Yahoo Finance

Sep 21, 2026

Sep 20, 2026

NeoGenomics Highlights NGS, MRD Growth Strategy at Morgan Stanley Conference - MarketBeat

Sep 20, 2026

Sep 18, 2026

NeoGenomics (NEO) Stock Looks Above Fair Value On Current Sales - Simply Wall Street

Sep 18, 2026

Sep 17, 2026

A Look at NeoGenomics Inc (NEO) After 5.0% Gain -- GF Value $16. - GuruFocus

Sep 17, 2026

Sep 17, 2026

NeoGenomics (NASDAQ:NEO): What's Behind Its New High? - Kalkine Media

Sep 17, 2026

Sep 17, 2026

NeoGenomics (NASDAQ:NEO) Sets New 52-Week HighShould You Buy? - MarketBeat

Sep 17, 2026

Sep 17, 2026

Neogenomics stock hits 52-week high at 19.78 USD By Investing.com - Investing.com Australia

Sep 17, 2026

Sep 17, 2026

Neogenomics stock hits 52-week high at 19.78 USD - Investing.com

Sep 17, 2026

Sep 17, 2026

NeoGenomics Q2 2026 Earnings: EPS Beat of 51% Overshadows Revenue SilenceEarnings Trend Analysis - careplusvn.com

Sep 17, 2026

Sep 15, 2026

NeoGenomics at Morgan Stanley conference: NGS, MRD drive growth By Investing.com - Investing.com Canada

Sep 15, 2026

Sep 14, 2026

Squarepoint Ops LLC Purchases 120,342 Shares of NeoGenomics, Inc. $NEO - MarketBeat

Sep 14, 2026

Sep 14, 2026

WINTON GROUP Ltd Purchases New Position in NeoGenomics, Inc. $NEO - MarketBeat

Sep 14, 2026

Sep 12, 2026

Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Sep 12, 2026

Sep 12, 2026

(NEO) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Sep 12, 2026

Sep 11, 2026

NEOGENOMICS, INC.COMMON STOCKGilbert Ray Cisneros, Jr. Congressional Trade on Aug. 07, 2026 - Quiver Quantitative

Sep 11, 2026

Sep 11, 2026

A Look Back at Testing & Diagnostics Services Stocks’ Q2 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack - Yahoo Finance

Sep 11, 2026

Sep 11, 2026

NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Sep 11, 2026

Sep 10, 2026

NeoGenomics, Inc. $NEO Shares Bought by First Light Asset Management LLC - MarketBeat

Sep 10, 2026

Sep 04, 2026

NeoGenomics Inc. (NEO) Key Financial Ratios – Valuation, Profitability & More - Value Research

Sep 04, 2026

Sep 03, 2026

NeoGenomics EVP Alicia Olivo Surrenders Shares for Tax Withholding Following Restricted Stock Vesting - Kalkine Media

Sep 03, 2026

Sep 03, 2026

Bank of New York Mellon Corp Takes Position in NeoGenomics, Inc. $NEO - MarketBeat

Sep 03, 2026

Sep 01, 2026

NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Business Wire

Sep 01, 2026

Aug 30, 2026

NeoGenomics Inc. (NEO) Peer Comparison – Compare with Others - Value Research

Aug 30, 2026

Aug 30, 2026

NeoGenomics Inc. (NEO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Aug 30, 2026

Aug 28, 2026

Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO), LeonaBio (LONA) and Solid Biosciences (SLDB) - The Globe and Mail

Aug 28, 2026

Aug 27, 2026

NeoGenomics Shares Rise After RaDaR ST Assay Gets Expanded Medicare Coverage - marketscreener.com

Aug 27, 2026

Aug 27, 2026

NeoGenomics Stock Just Turned Its First Profit, Creating an Optimal Entry Point - Yahoo Finance

Aug 27, 2026

Aug 26, 2026

NeoGenomics gains Medicare coverage for cancer MRD test By Investing.com - Investing.com Canada

Aug 26, 2026

Aug 26, 2026

NeoGenomics RaDaR ST wins expanded Medicare coverage for immunotherapy response monitoring - Bitget

Aug 26, 2026

Aug 26, 2026

NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring - Yahoo Finance

Aug 26, 2026

Aug 25, 2026

NeoGenomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo

Aug 25, 2026

Aug 25, 2026

NeoGenomics (NEO) COO converts 28K stock units into common shares - Stock Titan

Aug 25, 2026

Aug 24, 2026

NeoGenomics, Inc. (NEO) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Aug 24, 2026

Aug 21, 2026

NeoGenomics (NASDAQ:NEO) Healthcare Innovation Gains Attention - Kalkine Media

Aug 21, 2026

Aug 21, 2026

NeoGenomics (NASDAQ:NEO) Reaches New 12-Month HighHere's Why - MarketBeat

Aug 21, 2026

Aug 21, 2026

Neogenomics stock hits 52-week high at 16.93 USD By Investing.com - Investing.com Nigeria

Aug 21, 2026

Aug 21, 2026

Neogenomics stock hits 52-week high at 16.93 USD - Investing.com

Aug 21, 2026

Aug 21, 2026

NeoGenomics, Inc. Revenue Breakdown – NASDAQ:NEO - TradingView

Aug 21, 2026

Aug 17, 2026

NeoGenomics (NEO) Advances 1.44% to $16.17 as Buyers Hold Above Key SupportPercent Above MA - vinanet.vn

Aug 17, 2026

Aug 17, 2026

NeoGenomics (NASDAQ:NEO) Enters A New Growth Spotlight - Kalkine Media

Aug 17, 2026

Aug 17, 2026

NeoGenomics, Inc. (NASDAQ:NEO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Aug 17, 2026